Choksi Laboratories approves FY26 accounts at 33rd AGM
- Shareholders approved the audited balance sheet for FY26 ending March 31, 2026
- Sunil Choksi reappointed as director following retirement by rotation
- Himika Choksi reappointed as Whole-Time Director via special resolution
- AGM held virtually on September 18, 2026, with remote e-voting enabled
*this image is generated using AI for illustrative purposes only.
Choksi Laboratories concluded its 33rd Annual General Meeting on September 18, 2026. The company secured shareholder approval for its financial statements for the fiscal year ended March 31, 2026.
The meeting was conducted through video conference or other audio-visual means from the registered office in Indore, Madhya Pradesh. Sunil Choksi, Chairman and Managing Director, declared the meeting open after confirming the presence of quorum.
Key Resolutions Passed
Shareholders voted on three primary resolutions during the session. The outcomes are detailed below:
| Resolution Type | Description | Status |
|---|---|---|
| Ordinary | Adoption of Audited Balance Sheet for FY26 | Passed |
| Ordinary | Re-appointment of Sunil Choksi as Director | Passed |
| Special | Re-appointment of Himika Choksi as Whole-Time Director | Passed |
Sunil Choksi retires by rotation under Section 152(6) of the Companies Act, 2013, and was eligible for re-appointment. Himika Choksi was also approved for her role as a Whole-Time Director.
Voting Process
The company facilitated remote e-voting through the Central Depository Services (India) Limited platform. Shareholders holding shares as on September 11, 2026, could cast their votes between September 15 and September 17, 2026. Ms. Surbhi Agrawal served as the scrutinizer for the e-voting process to ensure transparency.
The meeting commenced at 12:30 pm and concluded at 12:42 pm. All directors, key managerial personnel, and auditors attended the proceedings virtually.
Historical Stock Returns for Choksi Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.20% | +7.14% | +50.06% | +80.72% | -6.02% | +980.33% |
How will the re-appointment of Sunil and Himika Choksi influence Choksi Laboratories' strategic direction for FY27?
What specific growth targets or operational milestones did management highlight during the AGM to justify shareholder confidence?
Are there any pending regulatory approvals or compliance issues that could impact the company's operations in the coming fiscal year?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
